Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-207557
Filing Date
2013-05-08
Accepted
2013-05-08 16:22:42
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d520349d10q.htm 10-Q 471083
2 EX-31.1 d520349dex311.htm EX-31.1 7841
3 EX-31.2 d520349dex312.htm EX-31.2 7868
4 EX-32.1 d520349dex321.htm EX-32.1 4376
  Complete submission text file 0001193125-13-207557.txt   3529001

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT immu-20130331.xml EX-101.INS 498769
6 XBRL TAXONOMY EXTENSION SCHEMA immu-20130331.xsd EX-101.SCH 34262
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE immu-20130331_cal.xml EX-101.CAL 47220
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE immu-20130331_def.xml EX-101.DEF 81158
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20130331_lab.xml EX-101.LAB 283103
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20130331_pre.xml EX-101.PRE 183560
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-12104 | Film No.: 13824835
SIC: 2835 In Vitro & In Vivo Diagnostic Substances